Galectin Therapeutics Inc. Share Price
GALTGalectin Therapeutics Inc. Stock Performance
Open $3.16 | Prev. Close $3.16 | Circuit Range N/A |
Day Range $3.01 - $3.16 | Year Range $1.12 - $7.13 | Volume 10,786 |
Average Traded $3.09 |
Galectin Therapeutics Inc. Share Price Chart
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
26-Feb-26 | $3.16 | $3.15 | +0.00% |
26-Feb-26 | $3.16 | $3.15 | -2.18% |
25-Feb-26 | $3.27 | $3.21 | +2.72% |
24-Feb-26 | $3.01 | $3.13 | +2.96% |
23-Feb-26 | $2.99 | $3.04 | +1.84% |
20-Feb-26 | $3.01 | $2.98 | +2.40% |
19-Feb-26 | $2.88 | $2.92 | +3.19% |
FAQs on Galectin Therapeutics Inc. Share Price
Can I buy Galectin Therapeutics Inc. shares in India?
What is the share price of Galectin Therapeutics Inc.?
What is the 5 year returns of Galectin Therapeutics Inc.?
What are the high & low stock price of Galectin Therapeutics Inc. today?
What is the 52-week high and low of Galectin Therapeutics Inc. stock?